Reported Jul 1, 2020 · Ongoing

amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000 tablets bottles, Distributed by: Amneal…

Amneal Pharmaceuticals of New York, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Amneal Pharmaceuticals of New York, LLC · 50 Horseblock Rd · Brookhaven, NY · 11719-9509

Is this the product you have?

  • amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000 tablets bottles
  • Distributed byAmneal Pharmaceuticals LLC Bridgewater, NJ 08807 NDC 53746-0178-10
Lot codes and dates
    • HF08618A
    • 6/30/2020
    • HF08718A
    • 6/30/2020
    • HF15418A
    • 7/31/2020
    • HF15518A
    • 7/31/2020
    • HH11818A
    • 9/30/2020
    • HJ00818A
    • 9/30/2020
    • HJ00918A
    • 9/30/2020
    • HJ01018A
    • 9/30/2020
Amount recalled
N/A

This recall covers 12 products

The agency filed one notice per product. You are reading one of them; the other 11 are below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Amneal Pharmaceuticals recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 7:19 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.